Tempest Therapeutics, Inc. Interest and Other Income
Tempest Therapeutics, Inc. (TPST) reported Interest and Other Income of $213.00 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2022-11-08
- Tempest Therapeutics, Inc. interest and other income for the quarter ending 2022-09-30 was $213.00K, a 238.10% increase year-over-year.
- Tempest Therapeutics, Inc. interest and other income for the quarter ending 2022-06-30 was $70.00K, a 2233.33% increase year-over-year.
- Tempest Therapeutics, Inc. interest and other income for the quarter ending 2022-03-31 was $3.00K, a 0.00% change year-over-year.
- Tempest Therapeutics, Inc. interest and other income for the quarter ending 2021-09-30 was $63.00K, a 2000.00% increase year-over-year.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month |
|---|---|---|---|
| 2022-09-30 | $213.00K 10-Q · filed 2022-11-08 | $283.00K derived: sum of 2 quarters · filed 2022-11-08 | $286.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $70.00K 10-Q · filed 2022-08-15 | $73.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $3.00K 10-Q · filed 2022-05-13 | ||
| 2021-09-30 | $63.00K 10-Q · filed 2022-11-08 | $66.00K derived: sum of 2 quarters · filed 2022-11-08 | $69.00K 10-Q · filed 2022-11-08 |
| 2021-06-30 | $3.00K 10-Q · filed 2022-08-15 | $6.00K 10-Q · filed 2022-08-15 | |
| 2021-03-31 | $3.00K 10-Q · filed 2022-05-13 | ||
| 2020-09-30 | $3.00K 10-Q · filed 2021-11-10 | $12.00K derived: sum of 2 quarters · filed 2021-11-10 | $87.00K 10-Q · filed 2021-11-10 |
| 2020-06-30 | $9.00K 10-Q · filed 2021-08-12 | $84.00K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |